logo-loader
viewOpen Orphan PLC

Open Orphan reports unprecedented growth opportunities and strong pipeline to build revenues

Open Orphan PLC's (LON:ORPH) Cathal Friel says they're targeting operational profitability by the third quarter of the year following its merger with hVIVO. Speaking to Proactive following the release of its full-year results Friel says they're seeing unprecedented growth opportunities as pharma focuses funding on Covid-19 and respiratory diseases.

Quick facts: Open Orphan PLC

Price: 11.7 GBX

AIM:ORPH
Market: AIM
Market Cap: £77.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan PLC targeting Q3 for profitability as it expands range of pharma...

Proactive Research analyst Emma Ulker says Open Orphan PLC's (LON:ORPH) full year 2019 results reflect a period of transition, as the company consolidated only six months of Venn revenues, with the focus being on integration and ongoing streamlining of the business, following the post–period...

1 week, 3 days ago

2 min read